Frick MA, Woodruff JL, Caudillo YM et al (2025) Orexin/Hypocretin modulates neuroinflammatory response to LPS in a sex and brain-region specific manner in young rats
Project 3: GLP-1R/GIPR agonists in promoting gastroenteropancreatic (GEP) NET progression Project Co-Leaders: Po Hien Ear, PhD (Basic Co-Leader) Joseph Dillon, MD (Clinical Co-Leader) James Howe, MD (Clinical Co-Leader) This timely investigation will define the role and impact of increasingly used obesity and diabetes drugs, GLP-1 and GIP receptor agonists like Ozempic, on GEPNET growth
Low energy: Decreased testosterone levels can result in fatigue and a general lack of energy
Preclinical Bridging Studies Prior to introducing the SC formulation into clinical studies, at a minimum, local tolerance must be established in a good laboratory practice toxicology study, as per Organisation for Economic Co-operation and Development (OECD) requirements
Poorly controlled diabetes creates glucose-rich environments conducive to Candida growth in bodily fluids and skin folds
